2005 sales of Pfizer Korea slow at 255,300 million won.

Pfizer Korea reported 2005 business performances as 255,300 MW of sales, about 0.93% down from the previous year, 44,780 MW of operating income, 2.02% up, 63,863 MW of ordinary income, which was 6,000 MW more than the previous year and 19,048 MW of net income, 12.12% up from the previous year.

The 2005 profitability ratio showed the operating income to sales at 17.54% (17.03% in 2004) and th...